Our latest news
What We’re Working On
Media Contact
Dan Budwick
dan@1abmedia.com
Bringing Meaningful Therapies from One to Many
-
January 24th, 2024
Actio Biosciences Appoints Samuel Collins, MBBS, Ph.D., MBA, as Chief Medical Officer as Company Advances Multiple Precision Medicine Programs Toward Clinical Development
Read More -
September 12th, 2023
Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases
Read More -
September 12th, 2023BioCentury
Actio seeks rare toeholds into common diseases with $55M A round
Read More -
September 12th, 2023Biopharma Dive
Actio, a precision medicine startup, launches with $55M and a mouse lab partnership
Read More -
September 12th, 2023GenEngNews
Lights, Camera: Actio Biosciences Launches to Bridge Common and Rare Disease Treatments
Read More